| Financial Year |
March 31 2023 |
| Monetary Funds |
1,438,582,799.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
850,241,489.82 |
| Accounts Receivable |
5,861,879,777.03 |
| Advances to Suppliers |
160,509,060.66 |
| Other Receivables |
91,703,343.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,864,393,609.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
233,358,856.04 |
| Total Current Assets |
14,011,460,905.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
27,632,411.79 |
| Fixed Assetes |
1,870,503,313.29 |
| Under-construction Projects |
5,587,951.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
306,670,159.55 |
| R&D expenses |
-- |
| Goodwill |
298,480,210.97 |
| Long-Term Deferred and Prepaid Expenses |
29,840,595.00 |
| Deferred Income Tax Assets |
270,985,504.51 |
| Other Non-Current Assets |
15,392,882.74 |
| Sub-Total of Non-Current Assets |
3,044,993,516.11 |
| Total Assets |
17,056,454,421.46 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,950,392,820.24 |
| Accounts Payable |
5,311,274,924.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
157,534,602.25 |
| Taxes Payable |
130,921,974.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
80,780,032.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
44,099,556.88 |
| Other Current Liabilities |
240,817,001.54 |
| Sub-Total of Current Liabilities |
10,926,242,985.22 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,182,418.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
183,130,118.02 |
| Total Liabilities |
11,109,373,103.24 |
| Paid-In Capital(Or Share Stock) |
649,537,963.00 |
| Capital Surplus |
3,428,125,861.71 |
| Surplus Reserve |
125,681,825.06 |
| LESS:Treasury Stock |
139,476,375.02 |
| Undistributed Profits |
1,789,333,262.57 |
| Minority Stockholder's Interest |
92,913,874.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,854,167,444.18 |
| Owner's Equity（Stockholder's Equity） |
5,947,081,318.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,056,454,421.46 |
